BOAI NKY MEDICAL HOLDINGS LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.85 CNY | -1.97% |
|
-1.28% | +15.58% |
| 04-26 | Boai NKY Medical Holdings Ltd. Proposes Final Cash Dividend for 2023 | CI |
| 04-25 | Boai NKY Medical Holdings Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2022 | 1.49B 205M 16.37B | Sales 2023 | 1.58B 219M 17.44B | Capitalization | 5.55B 766M 61.15B |
|---|---|---|---|---|---|
| Net income 2022 | 291M 40.16M 3.21B | Net income 2023 | 493M 68.04M 5.43B | EV / Sales 2022 | 4.69 x |
| Net cash position 2022 | 504M 69.6M 5.56B | Net cash position 2023 | 265M 36.51M 2.91B | EV / Sales 2023 | 3.34 x |
| P/E ratio 2022 |
28.5
x | P/E ratio 2023 |
11.9
x | Employees | 1,047 |
| Yield 2022 |
2.07% | Yield 2023 |
-
| Free-Float | 4.9% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.97% | ||
| 1 week | -1.28% | ||
| Current month | +9.74% | ||
| 1 month | +11.80% | ||
| 3 months | +28.39% | ||
| 6 months | +11.98% | ||
| Current year | +15.58% |
1 week
20.33
21.56
1 month
19.0822.00
Current year
12.0322.00
1 year
12.0327.26
3 years
11.5232.19
5 years
9.5132.19
10 years
8.4091.96
| Managers | Title | Age | Since |
|---|---|---|---|
Jun Zheng Zhang
CEO | Chief Executive Officer | 48 | 31/12/02 |
Ai Min Liu
DFI | Director of Finance/CFO | 51 | 31/12/94 |
Yun Xia Qu
BRD | Director/Board Member | 54 | 31/12/04 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Dong Hu Wang
BRD | Director/Board Member | 70 | 31/12/02 |
Chong Chao Yan
CHM | Chairman | 58 | 31/12/88 |
Jun Zheng Zhang
CEO | Chief Executive Officer | 48 | 31/12/02 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 20.85 | -1.97% | 12,013,100 |
| 25/04/24 | 21.27 | +0.47% | 6,752,805 |
| 24/04/24 | 21.17 | +2.52% | 5,889,964 |
| 23/04/24 | 20.65 | -0.82% | 4,690,630 |
| 22/04/24 | 20.82 | -1.42% | 4,193,331 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes
Boai NKY Medical Holdings Ltd., formerly Boai NKY Pharmaceuticals Ltd., is a China-based company principally engaged in the research, development, production and distribution of polyvinyl pyrrolidone (PVP) series products and polyvinyl methyl ether and maleic anhydride (PVME/MA) series products. The Companyâs main products include GBL, 2- pyrrolidone, N-vinylpyrrolidone (NVP) monomer, PVP-K series (PVPK), polyvinylpolypyrrolidone (PPVP), PVP- Iodine (PVP-I), related pharmaceutical intermediates and others. The Company's products are mainly used in daily chemical, medicine, liquor and beverage, pigments and coatings, textile, paper making, oil extraction, sensitive material, electronic and other industries. The Company distributes its products in domestic market and to overseas markets.
Sector
Specialty Chemicals
Calendar
23/05/2024
- Annual General Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +15.58% | 885M | |
| +11.47% | 63.22B | |
| -2.56% | 46.34B | |
| +14.04% | 39.97B | |
| +17.83% | 25.46B | |
| +7.64% | 18.68B | |
| -0.57% | 17.24B | |
| -21.73% | 15.81B | |
| +1.52% | 14.9B | |
| -19.10% | 13.74B |
- Stock Market
- Equities
- 300109 Stock
